Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Seminars in Immunopathology
Published in: Seminars in Immunopathology 1/2006

01-09-2006 | Introduction

Regulatory T cells

Author: Shimon Sakaguchi

Published in: Seminars in Immunopathology | Issue 1/2006

Login to get access

Excerpt

There is accumulating evidence that regulatory T cells (Tregs), once called suppressor T cells, are present in the normal immune system as an essential cellular component for maintaining immunologic self-tolerance and immune homeostasis. Their anomaly can be a cause of aberrant or excessive immune responses, including autoimmune and immunopathological diseases. This issue of Springer Seminars of Immunopathology brings together current efforts to understand how Tregs contribute to immune homeostasis and self-tolerance and how they can be exploited to control physiological and pathological immune responses. …
Metadata
Title
Regulatory T cells
Author
Shimon Sakaguchi
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Seminars in Immunopathology / Issue 1/2006
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-006-0043-2

Other articles of this Issue 1/2006

Seminars in Immunopathology 1/2006 Go to the issue

Review

Regulatory T cells in human autoimmune diseases

Review

Regulatory T cells in experimental autoimmune disease

Review

The role of virus-induced regulatory T cells in immunopathology

Review

Regulatory T cells in graft-versus-host disease

Review

Regulatory T cells and innate immune regulation in tumor immunity

Review

Regulatory T cells in pregnancy
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits